Coadministration of sitagliptin or metformin has no major impact on the adverse metabolic outcomes induced by dexamethasone treatment in rats
Bryanne Silva Figueiredo(Universidade Federal de Santa Catarina), Alex Rafacho(Universidade Federal de Santa Catarina), Francielle Batista D. Ferreira(Universidade Federal de Santa Catarina), Amanda Marreiro Barbosa(Universidade Federal de Santa Catarina), Henrik Ortsäter(Uppsala University), Cristiane dos Santos(Universidade Estadual de Campinas (UNICAMP))
Cited by 2
Related Papers
Glucocorticoid treatment and endocrine pancreas function: implications for glucose homeostasis, insulin resistance and diabetes
|Journal of Endocrinology|2014|214
A role for the putative cannabinoid receptor GPR55 in the islets of Langerhans
|Journal of Endocrinology|2011|119
High doses of dexamethasone induce increased β-cell proliferation in pancreatic rat islets
|American Journal of Physiology-Endocrinology and Metabolism|2009|106